Immunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches

scientific article published in November 2017

Immunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/10717544.2017.1391892
P698PubMed publication ID29069980

P2093author name stringFan Chen
Zhigang Cheng
Yun Xue
Houming Liu
Wanshui Shan
Qinying Yan
Xuyong Dai
Zhide Cheng
P2860cites workExtensively drug-resistant tuberculosis: epidemiology and managementQ26830094
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infectionQ29616521
Purification and characterization of a glucan from Bacillus Calmette Guerin and the antitumor activity of its sulfated derivativeQ30958025
Microneedle-based drug delivery systems: microfabrication, drug delivery, and safetyQ34005731
Effect of microneedle design on pain in human volunteersQ34048990
Micro-fractional epidermal powder delivery for improved skin vaccinationQ34229340
Immune surveillance in the skin: mechanisms and clinical consequencesQ34308222
Hyaluronan: its nature, distribution, functions and turnoverQ34435770
Bacillus Calmette-Guérin vaccination using a microneedle patch.Q35079453
Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosisQ35896225
Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergyQ36033148
Microneedles for drug and vaccine deliveryQ36164749
Minimally invasive protein delivery with rapidly dissolving polymer microneedlesQ36458988
Totally drug-resistant tuberculosis and adjunct therapies.Q38210265
Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges.Q38216995
Synthesis, characterization, antioxidant activity and neuroprotective effects of selenium polysaccharide from Radix hedysariQ38889180
Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999.Q39655329
T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infectionQ43863784
The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial.Q45987833
Immunization without needlesQ46308392
BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccinationQ47179130
Structure, chain conformation, and immunomodulatory activity of the polysaccharide purified from Bacillus Calmette Guerin formulationQ50237297
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectpolysaccharideQ134219
immunotherapyQ1427096
Mycobacterium tuberculosisQ130971
P304page(s)1648-1653
P577publication date2017-11-01
P1433published inDrug DeliveryQ5308838
P1476titleImmunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches
P478volume24

Reverse relations

cites work (P2860)
Q89128903Enhancement of Ag85B DNA vaccine immunogenicity against tuberculosis by dissolving microneedles in mice
Q52337140The current status, challenges, and future developments of new tuberculosis vaccines.
Q90672612Three-Dimensional (3D) Printed Microneedles for Microencapsulated Cell Extrusion

Search more.